Overzicht Proefschriften
Tips in using the search/filter fieldsDisplaying 51-100 of 278 results.
| Titel | Promovendus | Promotor 1 | Promotor 2 | Copromotor 1 | Copromotor 2 | Universiteit | Promotiejaar | Trefwoorden |
|---|---|---|---|---|---|---|---|---|
| Paving ways for personalizing drug therapy during pregnancy | Daud N.A.A., PhD | Wilffert B, prof. dr. | Kammen-Bergman J.E.H. van, dr. | Rijksuniversiteit Groningen (RUG) | 2017 | Personalized medicine; Drug therapy; Pregnancy; | ||
| Towards a system-based pharmacology approach to predict developmental changes in renal drug clearance in children | De Cock R.F.W., PhD | Knibbe C.A.J., prof. dr. | Danhof M., prof. dr. | Allegaert K., prof. dr. | Universiteit Leiden (UL) | 2014 | Paediatrics; Population PK; Aminoglycosides; Propylene glycol; GFR; Renal function; Antibiotics; Glomerular filtration; Developmental changes; Pharmacokinetics; Newborns; | |
| Treatment optimization of fluoropyrimidines as single agent and in combination therapy | Deenen M.J., PhD | Schellens J.H.M., prof. dr. | Beijnen J.H., prof. dr. | Cats A., dr. | Universiteit Utrecht (UU) | 2011 | Pharmacogenetics; Fluoropyrimidines; Capecitabine; 5-fluorouracil; Dihydropyrimidine dehydrogenase; Dihydropyrimidine dehydrogenase; DPD-deficiency; | |
| Pharmacogenetics of sunitinib in metastatic renal cell carcinoma | Diekstra M.H.M., dr | Guchelaar H.J., prof. dr. | Swen J.J., PhD | Universiteit Leiden (UL) | 2017 | Genetics; Pharmacogenetics; Renal function; | ||
| Clinical pharmacological aspects of mitochondrial function in muscle | Diemen M.P.J. van, PhD | Cohen A.F., prof. dr. | Nelissen R.G.H.H., prof. dr. | Groeneveld G.J., prof. dr. | Universiteit Leiden (UL) | 2021 | Clinical pharmacology; Huntington's disease; Mitochondrial function; Magnetic Resonance Spectroscopy; Sarcopenia; Phosphocreatine recovery rate; Knee; Total knee arthroplasty; Wearables; Peripheral blood mononuclear cells; Protoporphorin IX Triple State Lifetime techn; | |
| The influence of morbid obesity on the pharmacokinetics and pharmacodynamics of drugs in adolescents and adults : focus on propofol and nadroparin | Diepstraten J., PhD | Knibbe C.A.J., prof. dr. | Vinks A.A., prof. dr. | Dongen H.P.A. van, dr. | Ramshorst B. van, dr. | Universiteit Leiden (UL) | 2013 | Drug dosing; Low-molecular-weight heparines; Nadroparin; Obesity; Pharmacodynamics; Pharmacokinetics; Propofol; |
| Rational use of antibiotics | Dijkmans A.C. | Burggraaf J., prof. dr. | Universiteit Leiden (UL) | 2020 | Antibiotics; Pharmacokinetics;Flucloxacillin;Penicillin; Pheneticillin;Rifampin;Colistin;Fosfomycin | |||
| Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis | Dijkstra J.A., PhD | Werf T.S. van der, prof. dr. | Kosterink J.G.W., prof. dr. | Alffenaar J.W.C., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2017 | Personalized medicine; Tuberculosis; | |
| Clinical pharmacology of immuno-modulatory biotherapeutics : innovations in early drug development | Dillingh M.R., PhD | Burggraaf J., prof. dr. | Cohen A.F., prof. dr. | Moerland M., dr. | Universiteit Leiden (UL) | 2017 | Immuno-modulatory biotherapeutics; Drug development; | |
| An orchestra in need of a conductor challenges and opportunities in multi-infusion therapy | Doesburg F | Touw D.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2021 | multi-infusion therapy | |||
| Exploring the role of glucagon in glucose homeostasis | Dongen M.G.J. van, PhD | Cohen A.F., prof. dr. | Romijn J.A., prof dr | Burggraaf J., prof. dr. | Universiteit Leiden (UL) | 2015 | Glucagon; Diabetes mellitus; Glucose homeostasis; Glucagon challenge; Glucagon receptor antagonist; Insulin | |
| Appropriate prescribing for older people | Drenth-van Maanen A.C., PhD | Egberts A.C.G., prof. dr. | Jansen P.A.F., dr. | Marum R.J. van, prof. dr. | Universiteit Utrecht (UU) | 2013 | Prescribing; Elderly; Polypharmacy; Transitional pharmaceutical care; | |
| Unintended effects of anti-hyperglycaemic drugs studied in population-based cohorts | Driessen J.H.M., PhD | Bergh J.P.W. van den, prof. dr. | Vries F. de, prof. dr. | Onzenoort H.A.W. van, PhD | Universiteit Maastricht (UM) | 2017 | Hyperglycaemic drugs; Population-based; | |
| Vascular adaptation to pregnancy and relaxin | Drongelen J. van, PhD | Smits P., prof. dr. | Lotgering F.K., prof. dr. | Radboud Universiteit (RU) | 2014 | |||
| The role of endogenous H2S production during hybernation and forced hypothermia: towards safe cooling and rewarming in clinical practice | Dugbartey G.J., PhD | Henning R.H., prof. dr. | Bouma H.R., PhD | Rijksuniversiteit Groningen (RUG) | 2015 | |||
| Assessing long-term and rare adverse effects of medicines | Duijnhoven R.G., PhD | Boer A. de, prof. dr. | Hoes A.W., prof. dr. | Bruin M.L. de, prof. dr. | Straus S.M.J.M., dr. | Universiteit Utrecht (UU) | 2016 | Adverse effects; Case-control studies; Clinical trials; Cohort studies; Long-term consequences; Medicines; Regulatory; |
| Vascular aging from DNA damage to protection | Ďurik M., PhD | Danser A.H.J., prof. dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2012 | Cardiovascular disease; Pharmacology; | ||
| Tetrahydrocannabinol in the treatment of neuropsychiatric symptoms in dementia | Elsen G. van den, PhD | Olde Rikkert M., prof. dr. | Verkes R., prof. dr. | Marck M. van der, dr. ir. | Kramers C., dr. | Radboud Universiteit (RU) | 2016 | THC; geriatric medicine; pain; Dementia; |
| Therapeutic drug monitoring in tuberculosis treatment | Elsen S.H.J. van den | Alffenaar J.W.C., prof. dr. | Werf T.S. van der, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2020 | drug monitoring, tuberculosis treatment | ||
| Pharmacokinetics and optimal exposure of antifungal drugs in critically ill patients | Elst K.C.M. van der, PhD | Kosterink J.G.W., prof. dr. | Werf T.S. van der, prof. dr. | Uges D.R.A., prof. dr. | Alffenaar J.W.C., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2015 | |
| Readmission to primary care : the role of community pharmacists post-discharge | Ensing H.T., PhD | Bouvy M.L., prof. dr. | Koster E.S., PhD | Dooren A.A. van, dr. | Universiteit Utrecht (UU) | 2017 | Safety; Care continuity; Discharge; Pharmacist home visit; | |
| Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibition | Esch J.H.M. van, dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2008 | Cardiovascular disease; Pharmacology; Renin-angiotensin system; | |||
| The quantification of growth hormone secretion : application of model-informed drug development in acromegaly | Esdonk M.J van | Graaf P.H., Prof.dr. | Burggraaf J., prof. dr. | Stevens J., Dr. | Universiteit Leiden (UL) | 2019 | Endocrinology Pulsatile profiles Population modelling Pharmacokinetic Pharmacodynamic modelling Clinical trial simulation | |
| Pediatric type 1 and 2 diabetes mellitus : epidemiology, comorbidities, and medication utilization | Fazeli Farsani S., PhD | Boer A. de, prof. dr. | Knibbe C.A.J., prof. dr. | Vorst M.M.J. van der, dr. | Mantel-Teeuwisse A.K., dr. | Universiteit Utrecht (UU) | 2015 | Adolescents; Children; Comorbidities; Epidemiology; Medication use; Diabetes mellitus; UIPS; |
| Drug effects on the risk and prognosis of community-acquired pneumonia | Garde E.M.W. van de, dr. | Leufkens H.G.M., prof. dr. | Bosch J.M.M. van den, prof. dr. | Souverein P.C., dr. | Deneer V.H.M., dr. | Universiteit Utrecht (UU) | 2007 | Pneumonia; Adults; Clinical outcomes; Prevention; |
| Targeting the ileo-colonic region in inflammatory bowel disease | Gareb B | Kosterink J.G.W., prof. dr. | Frijlink H.W., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2021 | Targeting the ileo-colonic region in inflammatory bowel disease | ||
| Optimizing cancer therapy. A focus on molecular imaging | Gaykema S.B.M., PhD | Vries E.G.E. de, prof. dr. | Lub-de Hooge M.N., dr. | Rijksuniversiteit Groningen (RUG) | 2014 | |||
| Clinical pharmacology of genotype-directed anticancer therapy - Towards rational combination strategies | Geel R.M.J.M. van, PhD | Schellens J.H.M., prof. dr. | Beijnen J.H., prof. dr. | Huitema A.D.R., prof. dr. | Cats A., dr. | Universiteit Utrecht (UU) | 2016 | Cancer; Genetics; BRAF; Colorectal cancer; Combination therapy; p53-deficient ovarian cancer; AZD1775; Treatment individualization; |
| The more complex renin-angiotensin system: new insights into an old system | Gembardt F., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Renin-angiotensin system; | |||
| Integrated pharmaceutical care: cooperation between pharmacist, general practioner, and patient and the development of a pharmaceutical care plan | Geurts M.M.E., PhD | Gier J.J. de, prof. dr. | Brouwers J.R.B.J., prof. dr. | Graeff P.A. de, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2015 | ||
| Optimizing levofloxacin dose in the treatment of multidrug-resistant tuberculosis | Ghimire S. | Alffenaar J.W.C., prof. dr. | Touw D.J., prof. dr. | Werf T.S. van der, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2019 | ||
| Sex hormones and cardiometabolic risk | Glisic M., PhD | Danser A.H.J., prof. dr. | Franco Duran O.H., Prof.dr. | Roks A.J.M., dr. | Erasmus Universiteit Rotterdam (EUR) | 2018 | Epidemiology; Pharmacology; Risk factors; Sex hormonesCardiovascular disease; Metabolism; | |
| Renin-Synthesizing Cells and Beyond | Goes Martini A., PhD | Danser A.H.J., prof. dr. | Neves F.A.R., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2017 | Renin-angiotensin system; Renal function; | ||
| Mounting an attack on the glioblastoma triad : proliferation, invasion and resistance | Gooijer M.C. de, PhD | Beijnen J.H., prof. dr. | Tellingen O. van, dr. | Universiteit Utrecht (UU) | 2019 | Glioblastoma; Blood-brain barrier; Therapy development; Pharmacology; Cell biology; Combination therapy; Mouse models; | ||
| Novel pharmacometric techniques to quantify the pharmacodynamics of analgesics: Tools of the trade | Goulooze S.C., PhD | Knibbe C.A.J., prof. dr. | Hankemeier T., prof. dr. | Krekels E.H.J., PhD | Universiteit Leiden (UL) | 2020 | Population pharmacokinetics-pharmacodynamics; Repeated time-to-event modelling; Paediatric pharmacology; Pharmacometric methodology; Analgesia; Iatrogenic withdrawal; Postoperative pain; Item response theory (IRT); Analgesia and sedation; Real-world data; Paediatrics; Pharmacodynamics; Pharmacometrics; | |
| The role of efflux and influx transporters in the disposition of digitalis-like compounds | Gozalpour E., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 | ||||
| Towards better fall prevention - examining the interplay between factors that influence gait in older patients | Groot M.H. de, PhD | Beijnen J.H., prof. dr. | Lamoth C.J.C., dr. | Universiteit Utrecht (UU) | 2017 | Falls; Gait analysis; Accelerometry; Frailty; Osteoporosis; Maturation; Medication use; Medication use; Geriatrics; Older patients; | ||
| Acute and chronic pain after cardiac surgery | Gulik L. van, PhD | Knibbe C.A.J., prof. dr. | Tibboel D., prof. dr. | Bruins P., dr. | Universiteit Leiden (UL) | 2014 | Acute pain; Intensive Care Unit; Chronic pain; Cardiac surgery; Pain management; | |
| Vascular pharmacology of migraine and preeclampsia: Problems of the fair sex | Gupta S., dr. | Saxena P.R., prof. dr. | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2006 | Cardiovascular disease; Pharmacology; | |
| Cardiovascular molecular imaging | Haas H.J. de, PhD | Dierckx R.A.J.O., prof. dr. | Slart R.H.J.A., prof. dr. | Boersma H.H., dr. | Rijksuniversiteit Groningen (RUG) | 2018 | Pharmacology; Cardiovascular molecular imaging | |
| Effects of perioperative medication on hemodynamics and blood loss | Haelst I.M.M. van, PhD | Egberts A.C.G., prof. dr. | Kalkman C.J., prof. dr. | Klei W.A. van, prof. dr. | Universiteit Utrecht (UU) | 2013 | ||
| Adequate antimicrobial treatment in elderly patients | Haeseker M.B., PhD | Verbon A., prof. dr. | Bruggeman C.A.M.V.A., prof. dr. | Hoebe C.J.P.A., prof. dr. | Stolk L.M.L., dr | Universiteit Maastricht (UM) | 2015 | Antibiotics; Elderly; Drug dosing; |
| The role of pharmacogenetics in osteosarcoma | Hagleitner M.M., PhD | Hoogerbrugge P.M., prof. dr. | Guchelaar H.J., prof. dr. | Loo D.M.W.M. te, dr. | Coenen M.J.H., dr. | Radboud Universiteit (RU) | 2015 | Cancer; Osteosarcoma; Pharmacogenetics; Genetics; Chemotherapy; |
| Benefits and risks for the individual : anticoagulation for patients with atrial fibrillation | Ham H.A. van den, PhD | Leufkens H.G.M., prof. dr. | Klungel O.H., prof. dr. | Staa T.J. van, prof. dr. | Universiteit Utrecht (UU) | 2016 | Benefit-risk balance; Atrial fibrillation; Oral anticoagulants; Observational studies; Individuals; | |
| End-organ damage in diabetes: exploring innovative targets and therapies | Hamidi M., PhD | Henning R.H., prof. dr. | Buikema J.H., dr. | Deelman L.E., dr. | Rijksuniversiteit Groningen (RUG) | 2015 | Diabetes mellitus; | |
| Cognition in Huntington's disease : the influence of motor behaviour and time | Hart E.P. 't, PhD | Roos R.A.C., prof. dr. | Universiteit Leiden (UL) | 2013 | Huntington's disease; Cognition; Movement disorder; Executive functioning; Memory; P300; Motor behaviour | |||
| Improving the physical health of people with severe mental illness : the need for tailor made care and uniform evaluation of interventions | Hasselt F.M. van, PhD | Loonen A.J.M., prof. dr. | Oud M.J.T., dr. | Krabbe P.F.M., dr. | Rijksuniversiteit Groningen (RUG) | 2013 | ||
| Non-dispensing clinical pharmacists in general practice : training, implementation and clinical effects | Hazen A.C.M., PhD | Bouvy M.L., prof. dr. | Wit N.J. de, prof. dr. | Bont A.A. de, prof. dr. | Zwart D.L.M., dr. | Universiteit Utrecht (UU) | 2018 | Clinical pharmacist; General practice; Medication reviews; Polypharmacy; Hospitalization; Professional identity; |
| Prediction and prevention of chronic renal impairment in high-risk populations; type 2 diabetes, hypertension & lung transplantation | Hellemons M.E., PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Bakker S.J.L., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2012 | prediction and prevention of chronic renal impairment type 2 diabetes lung transplantation | |
| Medication safety through information technology; a focus on medication prescribing and administering. | Helmons P.J., PhD | Kosterink J.G.W., prof. dr. | Daniels C.E., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2014 | medication safety information technology prescribing and administering drugs |